1. Academic Validation
  2. Focal Adhesion Regulation as a Strategy against Kidney Fibrosis

Focal Adhesion Regulation as a Strategy against Kidney Fibrosis

  • ACS Chem Biol. 2025 Feb 21;20(2):464-478. doi: 10.1021/acschembio.4c00776.
Jiwen Geng 1 2 Kaikai Zheng 2 Peng Wang 2 Baihai Su 1 Qiang Wei 2 Xiaojing Liu 3
Affiliations

Affiliations

  • 1 Department of Nephrology, Kidney Research Institute, West China Hospital, Sichuan University, Chengdu 610041, China.
  • 2 College of Polymer Science and Engineering, College of Biomedical Engineering, State Key Laboratory of Polymer Materials and Engineering Sichuan University, Chengdu 610065, China.
  • 3 Department of Pediatric Dentistry, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University, and Shandong Key Laboratory of Oral Tissue Regeneration, Shandong Engineering Research Center of Dental Materials and Oral Tissue Regeneration, Shandong Provincial Clinical Research Center for Oral Diseases, Jinan 250012, China.
Abstract

Chronic kidney fibrosis poses a significant global health challenge with effective therapeutic strategies remaining elusive. While cell-extracellular matrix (ECM) interactions are known to drive fibrosis progression, the specific role of focal adhesions (FAs) in kidney fibrosis is not fully understood. In this study, we investigated the role of FAs in kidney tubular epithelial cell fibrosis by employing precise nanogold patterning to modulate Integrin distribution. We demonstrate that increasing ligand spacing disrupts Integrin clustering, thereby inhibiting FA formation and attenuating fibrosis. Importantly, enhanced FA activity is associated with kidney fibrosis in both human disease specimens and murine models. Mechanistically, FAs regulate fibrosis through mechanotransduction pathways, and our in vivo experiments show that suppressing mechanotransduction significantly mitigates kidney fibrosis in mice. These findings highlight the potential of targeting FAs as a therapeutic strategy, offering new insights into clinical intervention in kidney fibrosis.

Figures
Products